載入...
From Traditional to Targeted Immunotherapy in Myasthenia Gravis: Prospects for Research
Treatment of Myasthenia Gravis (MG) is still based on non-specific immunosuppression. Long-term high dose corticosteroids is still a major cause of side effects, in young as well as in elderly patients in whom comorbidities further increase the burden of chronic immunosuppression. Moreover, awarenes...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020-09-01
|
| 叢編: | Frontiers in Neurology |
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/article/10.3389/fneur.2020.00981/full |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|